FIORCARI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 4.787
AS - Asia 1.822
EU - Europa 1.805
SA - Sud America 243
AF - Africa 40
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.708
Nazione #
US - Stati Uniti d'America 4.706
GB - Regno Unito 610
SG - Singapore 536
CN - Cina 411
IT - Italia 326
HK - Hong Kong 282
VN - Vietnam 247
SE - Svezia 203
BR - Brasile 182
DE - Germania 182
RU - Federazione Russa 93
FI - Finlandia 92
BD - Bangladesh 89
UA - Ucraina 70
FR - Francia 58
TR - Turchia 55
CA - Canada 43
ID - Indonesia 36
IN - India 31
BG - Bulgaria 28
KR - Corea 26
ES - Italia 25
BE - Belgio 20
PL - Polonia 20
JP - Giappone 19
NL - Olanda 17
IQ - Iraq 16
CZ - Repubblica Ceca 13
IE - Irlanda 13
MX - Messico 13
PH - Filippine 13
ZA - Sudafrica 13
CL - Cile 12
AR - Argentina 11
AE - Emirati Arabi Uniti 10
PK - Pakistan 10
VE - Venezuela 10
MA - Marocco 9
AU - Australia 8
CO - Colombia 8
EC - Ecuador 8
UZ - Uzbekistan 8
RO - Romania 7
AT - Austria 6
JM - Giamaica 6
KE - Kenya 5
AZ - Azerbaigian 4
JO - Giordania 4
MY - Malesia 4
PY - Paraguay 4
SA - Arabia Saudita 4
BO - Bolivia 3
BZ - Belize 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
LT - Lituania 3
PE - Perù 3
BH - Bahrain 2
CH - Svizzera 2
CY - Cipro 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
IL - Israele 1
KW - Kuwait 1
LV - Lettonia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 8.708
Città #
Fairfield 521
Ashburn 503
Southend 446
Santa Clara 349
Singapore 313
Woodbridge 294
Hong Kong 281
Chandler 255
Houston 249
Cambridge 208
Seattle 206
San Jose 157
Wilmington 156
Ann Arbor 151
Nyköping 133
Modena 111
Dearborn 109
Jacksonville 104
Los Angeles 86
London 84
Chicago 82
Beijing 80
New York 73
Ho Chi Minh City 70
Council Bluffs 67
Helsinki 65
Hanoi 59
Hefei 58
Munich 48
Fremont 42
Milan 41
The Dalles 38
Salt Lake City 36
San Diego 30
Izmir 29
Jakarta 29
Princeton 29
Lauterbourg 28
Sofia 28
Moscow 27
Bremen 26
Dallas 26
Eugene 26
Seoul 25
Tampa 22
Buffalo 21
Brussels 20
Frankfurt am Main 19
Warsaw 18
Columbus 17
Phoenix 16
Bologna 15
Haiphong 15
Redwood City 15
São Paulo 15
Elk Grove Village 14
Orem 14
Dublin 13
Miami 13
Toronto 13
Atlanta 12
Boardman 12
Shanghai 12
Da Nang 11
Tokyo 10
Amsterdam 9
Brno 9
Falls Church 9
Baghdad 8
Brooklyn 8
Denver 8
Dong Ket 8
Madrid 8
Tashkent 8
Chennai 7
Des Moines 7
Dulles 7
Guangzhou 7
Montreal 7
Nuremberg 7
Rome 7
San Giuliano Milanese 7
Turku 7
Castelnuovo Rangone 6
Hillsboro 6
San Francisco 6
Shenyang 6
Boston 5
Brasília 5
Caracas 5
Johannesburg 5
Kunming 5
Lancaster 5
Las Vegas 5
Nairobi 5
Ninh Bình 5
Ottawa 5
Parma 5
Reggio Emilia 5
Stockholm 5
Totale 6.322
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 596
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 389
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 371
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 358
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 355
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 349
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 343
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 336
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 326
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 319
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 309
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 298
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 296
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 296
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 294
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 291
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 284
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 276
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 273
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 272
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 270
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 250
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 241
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 225
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 179
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 171
The dynamic functions of IRF4 in B cell malignancies 105
RUOLO DI GS-1101, INIBITORE DELLA PI3K DELTA, NEL DIALOGO CELLULARE TRA CELLULE DI LEUCEMIA LINFATICA CRONICA (CLL) E MICROAMBIENTE 63
Notch2, a Key Player in Chronic Lymphocytic Leukemia: Mechanism, Microenvironment Interactions, and Therapeutic Implications 6
Totale 8.793
Categoria #
all - tutte 32.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022628 52 55 49 28 22 57 26 32 62 56 119 70
2022/2023729 77 96 58 74 95 90 10 84 76 5 30 34
2023/2024450 15 19 27 56 80 49 41 65 6 7 35 50
2024/20251.325 37 25 13 117 215 200 103 82 188 59 103 183
2025/20262.660 191 93 175 297 478 178 338 104 266 255 150 135
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 8.793